+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Small Molecule API Contract Manufacturer Quality Benchmarking: A Look at Small & Emerging Biopharma

  • ID: 5019678
  • Report
  • March 2020
  • Region: Global
  • Industry Standard Research (ISR)
1 of 3

The Small Molecule API Contract Manufacturing Quality Benchmarking: A Look at Small & Emerging Biopharma report is a deep dive into the small and emerging biopharma landscape. The findings in this report will help small and emerging biopharma companies make more informed CMO decisions, and help CMOs optimize operational and marketing strategies to better accommodate this segment.

The publisher understands the need for a deeper dive regarding the small and emerging biopharma landscape. This report provides pharmaceutical companies and contract manufacturers comprehensive analysis of current outsourcing trends and practices, CMO selection drivers, and CMO perceptions and interactions. In addition, comparisons between small and emerging biopharma companies and the wider industry are made throughout this report. Findings are based on 93 service encounters from 42 respondents who have been involved in outsourced small molecule API projects in the past 18 months.

What You Will Learn:

Small & Emerging Drug Developers:

  • Make a more educated purchase of CMO services by understanding which manufacturers best fit your company’s needs
  • Uncover which CMO attributes drive outsourcing partner selection for outsourced small molecule API manufacturing as well as which CMO attributes have gained importance over the past 12 months among industry peers
  • Gain insight into CMO customer loyalty, based on customer satisfaction, willingness to recommend, and likelihood to use again

Contract Manufacturers:

  • Understand your company’s market awareness and positioning, and use this information to develop targeted messaging to small and emerging biopharma companies
  • Gain insight into drug developers’ outsourcing preferences and practices when it comes to CMO selection and CMO preference for outsourced small molecule API manufacturing

Major Topics:

  • Outsourcing Philosophies and Practices
  • CMO Selection Drivers
  • CMO Perceptions and Interactions
  • Study Data
  • Demographics
Note: Product cover images may vary from those shown
2 of 3

1. Outsourcing Philosophies and Practices

  • Primary Section Takeaways
  • Outsourced Manufacturing Activities
  • Outsourcing Drivers
  • Outsourcing Models
  • Large Molecule Product Offering
  • Large vs. Small Molecule Outsourcing
  • Preferred Providers
  • Number of Preferred Providers

2. CMO Selection Drivers

  • Primary Section Takeaways
  • Most Important CMO Attributes
  • CMO Attributes Gaining Importance

3. CMO Perceptions and Interactions

  • Primary Section Takeaways
  • CMO Familiarity
  • CMO Leaders - Unprompted
  • CMO Leaders - Prompted
  • Received Proposals
  • CMO Use
  • CMO Preference
  • CMO Preference Among Users
  • CMO Cost Perceptions
  • Summary Table
  • CMO Loyalty

4. Study Data

  • Outsourced Manufacturing Activities
  • Outsourcing Drivers
  • Outsourcing Models
  • Use of Preferred Providers
  • Number of Preferred Providers
  • Large Molecule Product Offering
  • Large vs. Small Molecule Outsourcing
  • CMO Selection Attributes
  • CMO Selection Attributes Gaining Importance
  • CMO Leaders - Unprompted
  • Other Responses (2%)
  • CMO Familiarity
  • CMO Leaders - Prompted
  • Received Proposals
  • CMO Use
  • CMO Preference
  • CMO Cost Perceptions

5. Demographics

  • Company Type
  • Headquarters Location
  • Office Location
  • Job Title
  • Decision-making Responsibility
  • Small Molecule Drug Substance Outsourcing
  • Contract Manufacturing Responsibilities
  • Involvement in Outsourced Manufacturing
  • Contract Manufacturing Involvement
  • Years of Industry Experience
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

Adroll
adroll